0
Sign In  | Subscribe

Coronary Risk Factors Collection
 121-140 of 161 Articles
ACP Journal Club |  19 May 2009
Irbesartan did not reduce all-cause death or CV hospitalization in heart failure and preserved ejection fraction
PDFPDF
Justin A. Ezekowitz, MD; Finlay A. McAlister, MD
Ann Intern Med. 2009;150(10):JC5-10. doi:10.7326/0003-4819-150-10-200905190-02010
ACP Journal Club |  21 April 2009
Review: Statins are effective for prevention of cardiovascular events in patients without coronary heart disease
PDFPDF
Finlay A. McAlister, MD
Ann Intern Med. 2009;150(8):JC4-5. doi:10.7326/0003-4819-150-8-200904210-02005
ACP Journal Club |  21 April 2009
Review: Metformin reduces risk for CV mortality compared with other oral diabetes drugs or placebo in type 2 diabetes
PDFPDF
Lorraine Lipscombe, MD, MSc, FRCPC
Ann Intern Med. 2009;150(8):JC4-8. doi:10.7326/0003-4819-150-8-200904210-02008
ACP Journal Club |  21 April 2009
Review: Oral drugs for gestational diabetes do not increase adverse maternal and neonatal outcomes more than insulin
PDFPDF
Denice Feig, MD
Ann Intern Med. 2009;150(8):JC4-9. doi:10.7326/0003-4819-150-8-200904210-02009
ACP Journal Club |  17 March 2009
Intensive and standard glucose control did not differ for major CV events or death in poorly controlled type 2 diabetes
PDFPDF
Gillian L. Booth, MD, MSc
Ann Intern Med. 2009;150(6):JC3-8. doi:10.7326/0003-4819-150-6-200903170-02008
ACP Journal Club |  17 March 2009
Reynolds Risk Score for men predicted cardiovascular events more accurately than traditional risk factors only
PDFPDF
Keane K. Lee, MD; Mark A. Hlatky, MD
Ann Intern Med. 2009;150(6):JC3-14. doi:10.7326/0003-4819-150-6-200903170-02014
ACP Journal Club |  17 February 2009
Telmisartan did not reduce a composite of CV death, MI, HF, or stroke in high-risk patients intolerant to ACE inhibitors
PDFPDF
Robin J. Taylor, MD
Ann Intern Med. 2009;150(4):JC2-6. doi:10.7326/0003-4819-150-4-200902170-02006
ACP Journal Club |  17 February 2009
Telmisartan did not prevent recurrent stroke or major cardiovascular events
PDFPDF
Michael A. Sloan, MD, MS
Ann Intern Med. 2009;150(4):JC2-9. doi:10.7326/0003-4819-150-4-200902170-02009
ACP Journal Club |  17 February 2009
Intensive insulin therapy reduced long-term risk for incident hypertension in type 1 diabetes
PDFPDF
Apostolos Tsapas, MD, PhD
Ann Intern Med. 2009;150(4):JC2-12. doi:10.7326/0003-4819-150-4-200902170-02012
ACP Journal Club |  20 January 2009
Applying evidence: What’s the next action?
PDFPDF
Paul Glasziou, MD
Ann Intern Med. 2009;150(2):JC1-2. doi:10.7326/0003-4819-150-2-200901200-02002
ACP Journal Club |  20 January 2009
Rosuvastatin prevented major cardiovascular events in persons with elevated C-reactive protein
PDFPDF
Denise L. Campbell-Scherer, MD, PhD; Victor M. Montori, MD, MSc
Ann Intern Med. 2009;150(2):JC1-4. doi:10.7326/0003-4819-150-2-200901200-02004
ACP Journal Club |  20 January 2009
Aspirin and/or antioxidants did not prevent CV events in diabetes and peripheral arterial disease
PDFPDF
Michael E. Farkouh, MD, MSc
Ann Intern Med. 2009;150(2):JC1-8. doi:10.7326/0003-4819-150-2-200901200-02008
ACP Journal Club |  20 January 2009
Pioglitazone reduced liver injury and improved fasting glucose in nonalcoholic steatohepatitis without diabetes
PDFPDF
Kristina Utzschneider, MD; Kris Kowdley, MD
Ann Intern Med. 2009;150(2):JC1-9. doi:10.7326/0003-4819-150-2-200901200-02009
ACP Journal Club |  20 January 2009
n-3 polyunsaturated fatty acids reduced morbidity and mortality in chronic heart failure
PDFPDF
James M. Brophy, MD, PhD
Ann Intern Med. 2009;150(2):JC1-11. doi:10.7326/0003-4819-150-2-200901200-02011
ACP Journal Club |  16 December 2008
Benefits of early intensive glucose control to prevent diabetes complications were sustained for up to 10 years
PDFPDF
Eoin P. O’Sullivan, MD; Sean F. Dinneen, MD
Ann Intern Med. 2008;149(12):JC6-4. doi:10.7326/0003-4819-149-12-200812160-02004
ACP Journal Club |  16 December 2008
Benefits of tight blood pressure control to prevent diabetes complications were not sustained
PDFPDF
Eoin P. O’Sullivan, MD; Sean F. Dinneen, MD
Ann Intern Med. 2008;149(12):JC6-5. doi:10.7326/0003-4819-149-12-200812160-02005
ACP Journal Club |  16 December 2008
A combination of telmisartan and ramipril increased renal outcomes in vascular disease or diabetes
PDFPDF
Arsh K. Jain, MD; Matthew A. Weir, MD
Ann Intern Med. 2008;149(12):JC6-7. doi:10.7326/0003-4819-149-12-200812160-02007
ACP Journal Club |  18 November 2008
Evidence in context: One person's poison is another's acceptable risk
PDFPDF
R. Brian Haynes, MD; Lawrence E. Hart, MB, BCh
Ann Intern Med. 2008;149(10):JC5-2. doi:10.7326/0003-4819-149-10-200811180-02002
ACP Journal Club |  18 November 2008
10-year risk for CV events was 10% to 56% in rheumatoid arthritis; risk was greatest for patients with CV risk factors
PDFPDF
Ami Schattner, MD
Ann Intern Med. 2008;149(10):JC5-14. doi:10.7326/0003-4819-149-10-200811180-02014
ACP Journal Club |  21 October 2008
Glycemic control was not affected by self-monitoring of blood glucose in type 2 diabetes
PDFPDF
Sumit R. Majumdar, MD, MPH
Ann Intern Med. 2008;149(4):JC4-4. doi:10.7326/0003-4819-149-8-200810210-02004
Advertisement

Annals of Internal Medicine

Other Resources

Copyright © 2013 The American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)